ADBiotech Co

ADBiotech Co Net Tangible Assets

The Net Tangible Assets of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 15.32 B KRW. In the previous year, Net Tangible Assets was 3.23 B KRW — a change of 373.78% (higher).

Net Tangible Assets

15.32 BKRW

YoY

373.78%

Last updated:

Net Tangible Assets of ADBiotech Co is 2025 15.32 B KRW. Net Tangible Assets of ADBiotech Co was 2024 3.23 B KRW. It decreases by 373.78% higher compared to the previous year.

The ADBiotech Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
4.50 B KRW
Jan 1, 2019
6.97 B KRW
Jan 1, 2020
9.32 B KRW
Jan 1, 2021
5.10 B KRW
Jan 1, 2022
16.18 B KRW
Jan 1, 2023
11.24 B KRW
Jan 1, 2024
3.23 B KRW
Jan 1, 2025
15.32 B KRW
The ADBiotech Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
15.32 BKRW+373.78%
3.23 BKRW-71.22%
11.24 BKRW-30.56%
16.18 BKRW+217.28%
5.10 BKRW-45.25%
9.32 BKRW+33.69%
6.97 BKRW+54.94%
4.50 BKRW+58.16%
2.84 BKRW+231.55%
857.61 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Net Tangible Assets of ADBiotech Co is 15.32 B KRW in 2025.

Net Tangible Assets of ADBiotech Co changed from 3.23 B KRW to 15.32 B KRW, representing a 373.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ADBiotech Co

All Key Metrics — ADBiotech Co